Cargando…
Protein C Pathway, Inflammation, and Pump Thrombosis in Patients With Left Ventricular Assist Devices
Use of left ventricular assist devices (LVADs) for management of advanced heart failure is becoming increasingly common; however, device associated thrombosis remains an important cause of mortality in this patient population. We hypothesize that inflammation in LVAD implanted patients dysregulates...
Autores principales: | Walenga, Jeanine M., Torres, Tania A., Jeske, Walter P., Schwartz, Jeffrey, Escalante, Vicki, Newman, Joshua D., Bakhos, Mamdouh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520922/ https://www.ncbi.nlm.nih.gov/pubmed/32970454 http://dx.doi.org/10.1177/1076029620959724 |
Ejemplares similares
-
Identification of Novel Hemostatic Biomarkers of Adverse Clinical Events in Patients Implanted With a Continuous-Flow Left Ventricular Assist Device
por: McClane, Nathan, et al.
Publicado: (2018) -
Left Ventricular Assist Device Pump Thrombosis in a Patient Treated with Apixaban
por: Alkhunaizi, Mansour A., et al.
Publicado: (2021) -
Systemic thrombolysis in the management of pump thrombosis in patients with left ventricular assist devices
por: Kortekaas, Kirsten A., et al.
Publicado: (2022) -
Advancements in left ventricular assist devices to prevent pump thrombosis and blood coagulopathy
por: Malone, Grainne, et al.
Publicado: (2022) -
Left ventricular assist device and pump thrombosis: the importance of the inflow cannula position
por: Kortekaas, Kirsten A., et al.
Publicado: (2022)